ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 52 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,927 | -18.0% | 27,175 | +12.4% | 0.00% | – |
| Q2 2023 | $86,547 | +64.2% | 24,175 | 0.0% | 0.00% | – |
| Q1 2023 | $52,702 | -80.2% | 24,175 | +9.0% | 0.00% | – |
| Q4 2022 | $266,765 | +94.7% | 22,175 | +4.6% | 0.00% | – |
| Q3 2022 | $137,000 | +41.2% | 21,200 | 0.0% | 0.00% | – |
| Q2 2022 | $97,000 | -47.0% | 21,200 | 0.0% | 0.00% | – |
| Q1 2022 | $183,000 | -39.6% | 21,200 | 0.0% | 0.00% | – |
| Q4 2021 | $303,000 | -35.0% | 21,200 | 0.0% | 0.00% | – |
| Q3 2021 | $466,000 | +64.1% | 21,200 | 0.0% | 0.00% | – |
| Q2 2021 | $284,000 | +32.1% | 21,200 | 0.0% | 0.00% | – |
| Q1 2021 | $215,000 | +138.9% | 21,200 | 0.0% | 0.00% | – |
| Q4 2020 | $90,000 | +63.6% | 21,200 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -26.7% | 21,200 | 0.0% | 0.00% | – |
| Q2 2020 | $75,000 | +17.2% | 21,200 | 0.0% | 0.00% | – |
| Q1 2020 | $64,000 | -41.3% | 21,200 | 0.0% | 0.00% | – |
| Q4 2019 | $109,000 | +60.3% | 21,200 | 0.0% | 0.00% | – |
| Q3 2019 | $68,000 | -10.5% | 21,200 | 0.0% | 0.00% | – |
| Q2 2019 | $76,000 | -1.3% | 21,200 | 0.0% | 0.00% | – |
| Q1 2019 | $77,000 | +20.3% | 21,200 | 0.0% | 0.00% | – |
| Q4 2018 | $64,000 | -37.9% | 21,200 | 0.0% | 0.00% | – |
| Q3 2018 | $103,000 | -34.8% | 21,200 | 0.0% | 0.00% | – |
| Q2 2018 | $158,000 | +14.5% | 21,200 | 0.0% | 0.00% | – |
| Q1 2018 | $138,000 | -27.7% | 21,200 | 0.0% | 0.00% | – |
| Q4 2017 | $191,000 | -9.5% | 21,200 | 0.0% | 0.00% | – |
| Q3 2017 | $211,000 | +27.9% | 21,200 | 0.0% | 0.00% | – |
| Q2 2017 | $165,000 | +26.9% | 21,200 | 0.0% | 0.00% | – |
| Q1 2017 | $130,000 | 0.0% | 21,200 | 0.0% | 0.00% | – |
| Q4 2016 | $130,000 | -15.6% | 21,200 | 0.0% | 0.00% | – |
| Q3 2016 | $154,000 | +33.9% | 21,200 | +53.5% | 0.00% | – |
| Q2 2016 | $115,000 | +25.0% | 13,807 | 0.0% | 0.00% | – |
| Q1 2016 | $92,000 | +300.0% | 13,807 | +408.0% | 0.00% | – |
| Q4 2015 | $23,000 | +53.3% | 2,718 | 0.0% | 0.00% | – |
| Q3 2015 | $15,000 | 0.0% | 2,718 | 0.0% | 0.00% | – |
| Q2 2015 | $15,000 | – | 2,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |